Login to Your Account

Safe harbor? Cytodyn drug tox like 'water,' enters HIV phase III

By Randy Osborne
Staff Writer

Thursday, August 6, 2015

Cytodyn Inc. CEO Nader Pourhassan told BioWorld Today that his firm's advance into phase III trials with a self-injectable biologic for HIV bought several years ago from Progenics Pharmaceuticals Inc. may augur an era of not only vastly safer but more effective therapy.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription